1. Liu, S.Y., et al., Perioperative Targeted Therapy for Oncogene-Driven NSCLC. (1872-8332 (Electronic)).
2. Chen, P.A.-O., et al., Non-small Cell Lung Cancer in China. (2523-3548 (Electronic)).
3. Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptations;Marchetti;Oncotarget,2022
4. Tumor immunology and immunotherapy of non-small-cell lung cancer;Cascone;Cold Spring Harb Perspect Med,2022
5. Distinct immune gene programs associated with host tumor immunity, neoadjuvant chemotherapy, and chemoimmunotherapy in resectable NSCLC;Rocha;Clin. Cancer Res.,2022